Invasive Haemophilus influenzae type b disease.
In this overview, the characteristics of Haemophilus influenzae type b (Hib) as an organism and the important clinical and diagnostic features of the diseases it causes are discussed. Important developments in vaccination and in the treatment and prevention of Hib disease are outlined.
McIntyre
P
P
Department of Paediatrics, Westmead Hospital.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016667:Bacterial Capsules; D002481:Cellulitis / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D002648:Child; D004826:Epiglottitis / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D005145:Face; D006192:Haemophilus Infections / Q000145:classification; D018073:Haemophilus Vaccines / Q000494:pharmacology / Q000627:therapeutic use; D006193:Haemophilus influenzae / Q000145:classification; D006801:Humans; D015994:Incidence; D007223:Infant; D008583:Meningitis, Haemophilus / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D009017:Morbidity; D011135:Polysaccharides, Bacterial / Q000494:pharmacology / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D011135:Polysaccharides, Bacterial